Peetz Christopher
Insider CIK 1614740 · TBRA Chief Financial Officer · ALPN Director · MIRM President and CEO, Director · ARQT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-10-06 | 2026-10-06 | 6,892 | — | $0 | 233,108 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-10-06 | 2026-10-06 | 5,305 | — | $0 | 169,695 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-10-06 | 2026-10-06 | 6,892 | $15.87 | $109.4K | 206,637 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-10-06 | 2026-10-06 | 5,305 | $19.19 | $101.8K | 199,745 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-09-01 | 2026-09-03 | 30,000 | — | $0 | 58,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-09-01 | 2026-09-03 | 21,688 | $98.91 | $2.15M | 194,440 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-09-01 | 2026-09-03 | 30,000 | $2.94 | $88.2K | 224,440 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-09-01 | 2026-09-03 | 8,312 | $98.08 | $815.2K | 216,128 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-09-01 | 2026-09-03 | 30,000 | — | $0 | 58,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-09-01 | 2026-09-03 | 21,688 | $98.91 | $2.15M | 194,440 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-09-01 | 2026-09-03 | 8,312 | $98.08 | $815.2K | 216,128 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-09-01 | 2026-09-03 | 30,000 | $2.94 | $88.1K | 224,440 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-08-10 | 2026-08-11 | 20,000 | — | $0 | 88,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-10 | 2026-08-11 | 2,300 | $100.14 | $230.3K | 194,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-10 | 2026-08-11 | 11,683 | $98.51 | $1.15M | 202,626 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-08-10 | 2026-08-11 | 20,000 | $2.94 | $58.8K | 214,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-10 | 2026-08-11 | 6,017 | $99.25 | $597.2K | 196,609 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-08-10 | 2026-08-11 | 20,000 | — | $0 | 88,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-10 | 2026-08-11 | 2,300 | $100.14 | $230.3K | 194,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-10 | 2026-08-11 | 6,017 | $99.25 | $597.2K | 196,609 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-10 | 2026-08-11 | 11,683 | $98.51 | $1.15M | 202,626 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-08-10 | 2026-08-11 | 20,000 | $2.94 | $58.7K | 214,309 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2026-07-15 | 2026-07-17 | 13,010 | — | $0 | 13,010 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2026-07-15 | 2026-07-17 | 21,486 | — | $0 | 21,486 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2026-07-15 | 2026-07-17 | 4,315 | — | $0 | 4,315 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-07-06 | 2026-07-08 | 20,000 | — | $0 | 108,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 1,975 | $123.74 | $244.4K | 196,019 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 1,710 | $124.79 | $213.4K | 194,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 4,181 | $122.34 | $511.5K | 197,994 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 12,134 | $121.65 | $1.48M | 202,175 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-07-06 | 2026-07-08 | 20,000 | $2.94 | $58.8K | 214,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-06-01 | 2026-06-02 | 30,000 | — | $0 | 128,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-01 | 2026-06-02 | 2,602 | $94.64 | $246.3K | 221,707 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-01 | 2026-06-02 | 16,595 | $95.34 | $1.58M | 205,112 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-01 | 2026-06-02 | 6,926 | $96.15 | $665.9K | 198,186 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-01 | 2026-06-02 | 1,973 | $97.56 | $192.5K | 196,213 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-01 | 2026-06-02 | 1,021 | $98.20 | $100.3K | 195,192 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-01 | 2026-06-02 | 883 | $99.66 | $88.0K | 194,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-06-01 | 2026-06-02 | 30,000 | $2.94 | $88.2K | 224,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-03-16 | 2026-03-17 | 40,985 | $91.98 | $3.77M | 194,309 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-03-15 | 2026-03-17 | 50,000 | — | $0 | 25,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-03-15 | 2026-03-17 | 25,000 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-03-15 | 2026-03-17 | 50,000 | — | $0 | 235,294 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-03-15 | 2026-03-17 | 25,000 | — | $0 | 185,294 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-02-02 | 2026-02-03 | 9,108 | $103.30 | $940.9K | 160,294 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 67,000 | — | $0 | 67,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 43,500 | — | $0 | 43,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-01-26 | 2026-01-27 | 6,831 | $96.19 | $657.1K | 169,402 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-01-23 | 2026-01-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-01-23 | 2026-01-27 | 12,500 | — | $0 | 176,233 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-01-22 | 2026-01-23 | 7,098 | $93.33 | $662.5K | 163,733 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 12,797 | — | $0 | 25,593 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 12,797 | — | $0 | 170,831 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | G Gift | 2025-12-31 | 2026-01-02 | 21,070 | — | $0 | 187,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-11-18 | 2025-11-20 | 19,133 | — | $0 | 150,867 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-11-18 | 2025-11-20 | 19,133 | $19.24 | $368.1K | 158,034 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-08-11 | 2025-08-12 | 40,000 | — | $0 | 158,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-08-11 | 2025-08-12 | 40,000 | $2.94 | $117.6K | 178,641 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-08-11 | 2025-08-12 | 40,000 | $62.00 | $2.48M | 138,641 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-08-07 | 2025-08-08 | 40,000 | — | $0 | 198,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-08-07 | 2025-08-08 | 40,000 | $2.94 | $117.6K | 178,641 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-08-07 | 2025-08-08 | 40,000 | $55.25 | $2.21M | 138,641 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-03-17 | 2025-03-18 | 27,279 | $44.21 | $1.21M | 138,641 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-03-15 | 2025-03-18 | 50,000 | — | $0 | 25,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-03-15 | 2025-03-18 | 50,000 | — | $0 | 165,920 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-03-03 | 2025-03-04 | 40,000 | — | $0 | 238,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-03-03 | 2025-03-04 | 20,608 | $47.19 | $972.5K | 115,920 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-03-03 | 2025-03-04 | 40,000 | $2.94 | $117.6K | 155,920 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-03-03 | 2025-03-04 | 19,392 | $46.61 | $903.9K | 136,528 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-02-03 | 2025-02-04 | 9,102 | $48.22 | $438.9K | 115,920 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-01-24 | 2025-01-27 | 6,837 | $47.92 | $327.6K | 125,022 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-01-23 | 2025-01-27 | 12,500 | — | $0 | 25,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-01-23 | 2025-01-27 | 12,500 | — | $0 | 131,859 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 38,390 | — | $0 | 38,390 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 153,550 | — | $0 | 153,550 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-01-07 | 2025-01-08 | 7,489 | $42.82 | $320.7K | 119,359 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2024-11-08 | 2024-11-14 | 65 | $21.05 | $1.4K | 126,848 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2024-07-23 | 2024-07-24 | 34,013 | — | $0 | 278,487 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2024-07-23 | 2024-07-24 | 34,013 | $2.94 | $100.0K | 126,783 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer | 2024-05-20 | 2024-05-20 | 1,900 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2024-05-10 | 2024-05-16 | 817 | $21.05 | $17.2K | 92,770 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2024-02-02 | 2024-02-05 | 6,013 | $26.19 | $157.5K | 104,112 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-01-23 | 2024-01-25 | 37,500 | — | $0 | 37,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-01-23 | 2024-01-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2024-01-08 | 2024-01-09 | 5,209 | $28.03 | $146.0K | 110,125 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-07-03 | 2023-07-05 | 5,498 | $25.65 | $141.0K | 115,334 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2023-05-10 | 2023-05-19 | 1,256 | $16.92 | $21.3K | 120,832 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-01-31 | 2023-02-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2023-01-31 | 2023-02-02 | 50,000 | — | $0 | 119,576 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-01-09 | 2024-03-18 | 5,159 | $20.62 | $106.4K | 91,953 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2022-11-10 | 2022-11-14 | 49 | $17.05 | $835 | 69,576 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2022-05-10 | 2022-05-12 | 1,500 | $13.57 | $20.4K | 69,527 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2022-01-06 | 2022-01-07 | 240,000 | — | $0 | 240,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2022-01-06 | 2022-01-07 | 40,000 | — | $0 | 68,027 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2021-11-24 | 2021-11-29 | 7,000 | $14.40 | $100.8K | 28,027 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-10-01 | 2021-10-01 | 3,672 | $19.26 | $70.7K | 21,027 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2021-09-29 | 2021-10-01 | 21,875 | — | $0 | 24,699 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2021-09-23 | 2021-09-24 | 1,900 | $10.17 | $19.3K | 1,900 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2021-09-23 | 2021-09-27 | 1,900 | $10.17 | $19.3K | 1,900 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2021-05-10 | 2021-05-12 | 1,453 | $14.62 | $21.2K | 2,824 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2021-01-07 | 2021-01-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2021-01-04 | 2021-01-05 | 7,650 | — | $0 | 7,650 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2020-12-23 | 2020-12-28 | 3,000 | $18.76 | $56.3K | 199,570 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2020-12-23 | 2020-12-28 | 2,000 | $18.60 | $37.2K | 201,570 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2020-11-10 | 2020-11-12 | 1,371 | $15.27 | $20.9K | 1,371 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2020-01-10 | 2020-01-14 | 170,000 | — | $0 | 170,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2020-01-02 | 2020-01-06 | 7,650 | — | $0 | 7,650 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-09 | 2019-09-10 | 2,320 | $11.35 | $26.3K | 196,570 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-09 | 2019-09-10 | 2,000 | $10.90 | $21.8K | 194,250 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-09-06 | 2019-09-10 | 4,750 | $10.91 | $51.8K | 192,250 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2019-01-02 | 2019-01-04 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2018-04-20 | 2018-04-24 | 7,650 | — | $0 | 7,650 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 31,091 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 85,000 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 101,000 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 68,732 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 101,000 | — | $0 | 101,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-05-15 | 2015-05-18 | 85,000 | — | $0 | 85,000 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-06 | 2015-05-06 | 68,732 | — | $0 | 68,732 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-06 | 2015-05-06 | 31,091 | — | $0 | 99,823 | SEC↗ |